MET logo

METLIFE INC

METNYSE
๐Ÿ† #244 by market capEarnings Nov 4US Equity
$94.55โ–ผ $1.26 (โˆ’1.33%)
Live
๐Ÿ””
Track MET
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 1.3%
7dโ–ผ 1.4%
14dโ–ผ 3.8%
30dโ–ผ 2.1%
ytdโ–ฒ 19.7%
1yโ–ฒ 15.2%
๐ŸฆMarket Cap
$60.83B
Mid Cap
๐Ÿ“ˆRevenue Growth (YoY)
+10.2%
Healthy
๐Ÿ“ŠGross Margin
25.6%
Moderate
๐Ÿ’ตFCF Margin
21.1%
Strong
โš–๏ธP/S Ratio
0.8x
Cheap
Otter Score
52
Weak

Trading Snapshot

Day Range
$93.18 โ€“ $96.08
52-Week Range
$67.33 โ€“ $100.93
Volume
$3.27B
Avg Volume
$3.42B
Shares Outstanding
643.4M
Next Earnings
Dec 5, 2026

Fundamentals Snapshot

Annual Revenue
$77.08B
Last Q Revenue
$18.88B
P/E Ratio
18.4
P/S Ratio
0.8x
EPS (TTM)
$5.56
Dividend Yield
2.40%
Dilution (1yr)
โˆ’4.7%

Why Investors Own MET

  • โœ“High-growth profile โ€” revenue up -7.3% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 65% gross margin and 7% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

MET logo

METLIFE INC

MET
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$77.1Bโ–ฒ +10.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
36.4%โ–ฒ +33.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
$4.7Bโ–ผ โˆ’17.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$18.1Bโ–ฒ +19.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
665.0Mโ–ผ โˆ’4.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$1.8Bโ–ฒ +$496M YoY
StockOtter ยท stockotter.space

About METLIFE INC

MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
52/100

Analyst Price Target

โ“˜
Average Target
$93.06
โ–ผ โˆ’1.6% Downside
High Target$102.60
Low Target$81.42
Based on 28 analysts

Latest News & Updates

Zacks Investment Researchยท7d ago

Can MetLife's Group Benefits Segment Maintain Its Momentum?

MET's Group Benefits earnings jump 25% in Q2 2026, fueled by stronger underwriting and demand, but some mortality gains may fade.

Fool - Investing Newsยท9d ago

The 30-Year Treasury Yield Just Hit a 19-Year High. Life Insurers Reinvest at Those Rates for Decades.

Life insurers generally benefit from higher rates, but there are some negatives to consider.

Zacks Investment Researchยท12d ago

3 Life Insurers to Watch as Annuity Sales Hit First-Half Record Highs

Record annuity demand creates opportunities for Prudential, Principal Financial and MetLife as retirement needs and pension solutions grow.

GuruFocusยท13d ago

MetLife Investment Management Closes Galaxy 38 CLO

MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced the close of Galaxy 38 CLO, Ltd.

GuruFocusยท14d ago

RYBREVANT FASPROโ„ข (amivantamab and hyaluronidase-lpuj) plus LAZCLUZEยฎ (lazertinib) with prophylactic strategies shows low rates of treatment-related events at WCLC 2026

RYBREVANT FASPROรขย„ยข (amivantamab and hyaluronidase-lpuj) plus LAZCLUZEร‚ (lazertinib) with prophylactic strategies shows low rates of treatment-related events a

Defense Worldยท15d ago

Global Indemnity Group (NASDAQ:GBLI) & MetLife (NYSE:MET) Head-To-Head Analysis

MetLife (NYSE: MET - Get Free Report) and Global Indemnity Group (NASDAQ: GBLI - Get Free Report) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of the